Navigation Links
Branded Pharmaceutical Websites Continue to Be Most Impactful in Driving Conversions Among Prospects and Patients
Date:3/21/2011

RESTON, Va., March 21, 2011 /PRNewswire/ -- comScore, Inc. (Nasdaq: SCOR), a leader in measuring the digital world, today released results from its fifth annual Online Marketing Effectiveness Benchmarks for the Pharmaceutical Industry. The study supports previous findings that exposure to online display advertising and branded websites provides a positive lift in awareness and favorability toward pharmaceutical brands. Visitation to branded websites also continues to provide the most significant lifts in prospect conversion and patient refills. Conducted in conjunction with marketing innovation consultancy Evolution Road LLC, the study aims to provide marketers with insight into the impact of various online marketing activities on brand awareness, favorability, and sales.

(Logo: http://photos.prnewswire.com/prnh/20080115/COMSCORELOGO)

Included in this study were results from exposure to banner ads, rich media, search marketing and branded sites, both among patients and prospects. The study examined data from surveys conducted over the past few years and comScore's permission-based one million person U.S. panel.

"With online marketing as an integral part of any comprehensive pharmaceutical marketing plan, it's important to understand how various online channels affect consumers' knowledge of a brand and propensity to use that brand," said John Mangano, vice president of comScore health marketing solutions. "Our benchmarking data continue to show that branded websites have the greatest impact on conversions and also reinforce the significance of display and search advertising in increasing awareness and favorability toward a brand."

Branded Websites Most Effective in Driving ConversionsSupporting previous findings, the study found that visitation to a branded website generated the greatest positive lifts in conversion. Existing patients increased their refill rate 15.5 percentage points more than those who did not visit the site.  The percentage of prospects beginning treatment after visiting a branded site was 8.8 percentage points higher than prospects with no exposure to the branded site.Incremental Effect on New Patient Starts and Adherence/Next Fill vs. ControlSource: Online Marketing Effectiveness Benchmarks for the Pharmaceutical Industry(2011 Release)ProspectsPatientsNew Patient StartsAdherence/Next FillExposed & Interacted (Rich Media*)

No Statistically Significant Lift

No Statistically Significant LiftVisited Branded Website

+8.8

+15.5* Defined as interactive digital mediaExposure to Display Advertising Causes Increases in Brand Awareness and FavorabilityThe study also found that exposure to online display advertising and branded websites have a positive impact on awareness and favorability among both prospects and patients. For prospects, exposure to a display ad increased both aided and unaided brand awareness by 2.8 and 1.8 percentage points, respectively. The impact is greater for exposure and interaction with rich media ads, showing a 3.1-percentage point increase for aided brand awareness and a 5.5-percentage point increase for unaided brand awareness.  For patients, favorability was increased only by exposure and interaction with rich media ads, showing a 4.1-percentage point lift.

Apart from online advertising, branded pharma websites also continued to have a significant impact on awareness and favorability among patients and prospects. Prospects exhibited a 16.9-percentage point lift in favorability after visiting a branded website, while patients reported a 15.6-percentage point lift.Incremental Effect on Brand Awareness and Favorability Over Control Among Prospects and PatientsSource: Online Marketing Effectiveness Benchmarks for the Pharmaceutical Industry(2011 Release)ProspectsPatientsMarketing ActivityAided Brand
AwarenessUnaided Brand
AwarenessBrand
FavorabilityBrand
FavorabilityExposed Only to Online Ads

+2.8

+1.8

No Statistically Significant Lift

No Statistically Significant LiftExposed to and Interacted with Online Ads (Rich Media*)

+3.1

+5.5

No Statistically Significant Lift

+4.1Visited Branded Website

+14.1

+13.4

+16.9

+15.6* Defined as interactive digital mediaThe Online Marketing Effectiveness Benchmarks for the Pharmaceutical Industry also provides insight into lifts provided by various kinds of search-referred traffic to branded websites. To request a copy of the report or for more information on comScore Pharmaceutical and Healthcare Solutions, please contact John Mangano at jmangano@comscore.com.

About comScore Pharmaceutical and Healthcare SolutionscomScore Pharmaceutical Solutions delivers in-depth information needed to understand the impact that brand, condition-specific, and health websites have on consumers' brand awareness, conversion, and patient compliance as well as insights into health care professionals' online usage. comScore's products deliver actionable insight to help refine consumer profiles, identify key alliances, optimize interactive marketing initiatives, benchmark against the competition and accurately measure the ROI of Web site and online marketing programs. For more information, please visit http://www.comscore.com/Industry_Solutions/Pharmaceutical.

About comScorecomScore, Inc. (NASDAQ: SCOR) is a global leader in measuring the digital world and preferred source of digital business analytics. For more information, please visit www.comscore.com/companyinfo.

About Evolution RoadEvolution Road is a marketing innovation consultancy focused on helping brands leverage digital channels to drive their business. Evolution Road is bringing its vision to life - that digital marketing will dramatically improve how pharmaceutical brands are marketed for the benefit of consumers, physicians and healthcare brands. To that end, Evolution Road has helped millions of consumers and healthcare professionals make more informed healthcare choices and has delivered over $1 billion dollars in incremental top-line revenue for its clients at an ROI of over 4:1. For more information, please contact Paul Ivans at pivans@evolutionroad.com, or visit www.evolutionroad.com.

Follow us on Twitterhttp://twitter.com/comScorehttp://twitter.com/gfulgoni
'/>"/>

SOURCE comScore, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms
2. Lupin Expands Branded Play
3. Warner Chilcott Completes Acquisition of P&Gs Global Branded Prescription Pharmaceuticals Business
4. Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013
5. International Merchant Advisors to Develop Organic Science Branded Medical Marijuana Product Line
6. Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe
7. Reportlinker Adds Spain Pharmaceutical Market Overview - Price cuts set to negatively impact both branded and generics companies
8. GNC Teams With Sakar International for Branded Health and Wellness Product Line
9. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... and EDMONTON, Alberta , July ... and the University of Alberta in ... in Nature,s partner journal, Schizophrenia 1 , demonstrating ... instances of schizophrenia with 74% accuracy. This retrospective ... of specific symptoms in schizophrenia patients with significant ...
(Date:7/21/2017)... , July 21, 2017  Endo International plc (NASDAQ: ... a comprehensive review of its manufacturing network, the Company ... distribution facilities in Huntsville, Alabama . ... place over the next 12 to 18 months. The ... by declining volumes of commoditized products and these restructuring ...
(Date:7/20/2017)... , July 20, 2017  Prime Therapeutics LLC (Prime) ... Gavras , M.D., following today,s Institute for Clinical and Economic ... on the effectiveness and value of abuse-deterrent formulations (ADF) ... the policy roundtable at the meeting. ... a material cost benefit to the use of abuse-deterrent formulations ...
Breaking Medicine Technology:
(Date:7/24/2017)... ... 2017 , ... SignatureCare Emergency Center is looking to award their ... to a deserving student. Get your applications in now as the deadline is ... Castillo who is a nursing student at Prairie View A&M University with a 3.45 ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... Oakland, California effectively destroyed the construction site and threatened numerous homes and businesses ... 7th article on NBCLosAngeles.com. Los Angeles Area consulting firm Fire Protection ...
(Date:7/24/2017)... CLARA, CA (PRWEB) , ... July 24, 2017 , ... ... and financial organizations, today announced it has partnered with WALLIX to expand ... Special Publication 800-171 . , There are a number of ways to address the ...
(Date:7/24/2017)... California (PRWEB) , ... July 24, 2017 , ... ... of autologous fat (adipose) transfer systems announces the issuance of United States Patent ... patent) for its adipose filtration technology. The '398 and '324 patents cover ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... sleep management solution focused on delivering end-to-end sleep health care at scale, ... Recent literature shows that adherence rates for positive airway pressure (PAP) therapy, the ...
Breaking Medicine News(10 mins):